Aya Shiba-Ishii
8PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|May 27, 2024
Histologic transformation of non-small-cell lung cancer in response to tyrosine kinase inhibitors: Current knowledge of genetic changes and molecular mechanisms.Aya Shiba-Ishii, Noriko Takemura, Hitomi Kawai
|Jul 08, 2022
Mutational landscape of primary breast angiosarcoma with repeated resection and recurrence over a 15-year period: A case report.Fumiya Teruyama, Akihiro Kuno, Yoshihiko Murata
|Oct 10, 2021
Ovarian carcinoma immunoreactive antigen domain 2 controls mitochondrial apoptosis in lung adenocarcinoma.Jeongmin Hong, Aya Shiba-Ishii, Yunjung Kim
|Jul 29, 2021
Significance of stratifin in early progression of lung adenocarcinoma and its potential therapeutic relevance.Aya Shiba-Ishii
|May 31, 2019
Carcinogen-induced tumors in SFN-transgenic mice harbor a characteristic mutation spectrum of human lung adenocarcinoma.Yunjung Kim, Aya Shiba-Ishii, Karina Ramirez
|Oct 16, 2018
High expression of ovarian cancer immunoreactive antigen domain containing 2 (OCIAD2) is associated with poor prognosis in lung adenocarcinoma.Mai Sakashita, Shingo Sakashita, Yoshihiko Murata
Pageof 2
